Drug Addiction Treatment Act of 2000
Official title: To amend the Controlled Substances Act with respect to registration requirements for practitioners who dispense narcotic drugs in schedule IV or V for maintena… Show full official titleShow less
Official title: To amend the Controlled Substances Act with respect to registration requirements for practitioners who dispense narcotic drugs in schedule IV or V for maintenance treatment or detoxification treatment.
More subjectsShow fewer subjects
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Jul 19, 2000 | House · vote #416 | On Motion To Suspend the Rules and Pass, As Amended | Passed | 412–1 | See who voted → |
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 740.
Requires that: (1) the practitioner, before dispensing schedule IV-V drugs to patients for maintenance or detoxification treatment, submit to the Secretary a notification of intent to begin dispensing such drugs for that purpose, including certifications that the practitioner is a "qualifying physician" (defined to mean a physician who is licensed under State law and meets specified training and experience requirements), and has the capacity to refer the patients for appropriate counseling and other appropriate ancillary; and (2) the schedule IV-V drugs have been approved for use in maintenance or detoxification treatment and have not been the subject of an "adverse determination" (i.e., requires additional standards regarding the qualifications of practitioners to provide such treatment, or requires standards regarding the quantities of the drugs that may be provided for unsupervised use).
Sets forth specified procedural requirements to make the waiver effective. Directs the Secretary to assign a unique identifier to each notification of the intent of a practitioner to dispense schedule IV-V drugs to patients for maintenance or detoxification treatment, and to provide to the Attorney General all information contained in such notifications.
Authorizes the Secretary and the Attorney General, during the three-year period beginning on the date of this Act's enactment, to make determinations regarding whether: (1) treatments provided under such waivers have been effective forms of maintenance and detoxification treatment in clinical settings; (2) such waivers have significantly increased the availability of such treatment; and (3) such waivers have adverse public health consequences. Authorizes the Secretary or the Attorney General, after consulting each other, to terminate the waiver mechanism after announcing their decision in the Federal Register. Authorizes appropriations to assist the Secretary with the additional duties established for the Secretary pursuant to this Act.
- Engrossed in House Formatted Text PDF
- Introduced in House Formatted Text PDF
- Placed on Calendar Senate Formatted Text PDF
- Reported in House Formatted Text PDF
Cite this page
U.S. Congress. (2026). H.R. 2634: Drug Addiction Treatment Act of 2000. 106th Congress. Open America. https://openamerica.io/bill/106-HR-2634/
"H.R. 2634: Drug Addiction Treatment Act of 2000." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HR-2634/.
H.R. 2634, 106th Cong. (2026), https://openamerica.io/bill/106-HR-2634/.
[H.R. 2634: Drug Addiction Treatment Act of 2000](https://openamerica.io/bill/106-HR-2634/)